LEARNING OBJECTIVES
At the conclusion of this activity, participants will:
• Role of Hiperthermic Intraperitoneal Chemotherapy (HIPEC) and Pressurized Intra Peritoneal Aerosolized Chemotherapy (PIPAC) as part of the multidisciplinary treatment options for peritoneal carcinomatosis.
• Understand indications and contraindications for HIPEC and PIPAC procedures
• Learn limitations of cytoreductive surgery (CRS) and HIPEC in aggressive cancer etiologies

Session date: 
06/30/2025 - 12:00pm to 1:00pm CDT
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please login or create an account to proceed.
Speaker Name: 
Mecker Moller, MD